Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
4DMedical Ltd ( (AU:4DX) ) has issued an announcement.
4DMedical Limited announced the completion of a A$5.5 million share placement to institutional investors and the launch of a A$7 million underwritten Share Purchase Plan (SPP) for eligible shareholders in Australia and New Zealand. The funds raised will support the company’s commercialization efforts and general working capital. This financial initiative reflects the company’s ongoing commitment to expanding its market presence and enhancing its product offerings, which has resulted in strong growth in site numbers, scan volume, and revenue per scan.
More about 4DMedical Ltd
4DMedical Limited is a respiratory imaging technology company focused on transforming lung health with innovative solutions. The company is known for its XV LVAS® product, which received FDA clearance and is part of a comprehensive portfolio aimed at improving healthcare IT systems connectivity.
YTD Price Performance: 13.54%
Average Trading Volume: 898,025
Technical Sentiment Consensus Rating: Hold
Current Market Cap: A$223.6M
See more data about 4DX stock on TipRanks’ Stock Analysis page.
